Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Mar 5, 2026

Extraction of Histones from Clinical Specimens for Epigenetic Profiling by Mass Spectrometry

Extraction of Histones from Clinical Specimens for Epigenetic Profiling by Mass Spectrometry

Published on: November 21, 2025

Global histone modification fingerprinting in human cells using epigenetic reverse phase protein array.

Marina Partolina¹, Hazel C Thoms¹, Kenneth G MacLeod²

¹Synthetic Epigenetics Laboratory, MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh , Edinburgh, UK.

Cell Death Discovery

|March 23, 2017

Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Loss of p62 Binding Allows TIF-IA Accumulation in Senescence, Which Promotes Phenotypic Changes to Nucleoli and the Senescence Associated Secretory Phenotype.

Aging cell·2025

Same author

Elevated plasma glucose links intrafollicular bile acids to altered embryological outcomes in IVF patients.

Journal of ovarian research·2025

Same author

Chameau (HBO1) regulates starvation resistance in <i>Drosophila melanogaster</i> in a temperature-dependent manner.

Life science alliance·2025

Same author

Deficiency of the Synaptic Adhesion Protein Leucine-Rich Repeat Transmembrane Protein 4 Like 1 Affects Anxiety and Aggression in Zebrafish.

Acta physiologica (Oxford, England)·2025

Same author

Ezh2 Shapes T Cell Plasticity to Drive Atherosclerosis.

Circulation·2025

Same author

Targeting the PREX2/RAC1/PI3Kβ Signaling Axis Confers Sensitivity to Clinically Relevant Therapeutic Approaches in Melanoma.

Cancer research·2024

This summary is machine-generated.

Histone acetylation, crucial for gene regulation, is targeted by new cancer therapies. This study introduces a novel assay to measure histone modifications, showing N-acetylated amino acids can boost therapeutic effects.

Area of Science:

Epigenetics and Molecular Biology
Cancer Research
Drug Discovery

Background:

Histone modifications, particularly acetylation and deacetylation, are key regulators of genomic functions.
Dysregulation of histone modifications is implicated in carcinogenesis, driving research into epigenetic therapies.
Current understanding of epigenetic modifications' link to cellular phenotypes and the role of cellular metabolites is incomplete.

Purpose of the Study:

To develop and validate a novel assay for robustly measuring global histone modifications.
To assess the impact of histone deacetylase (HDAC) inhibitors on histone acetylation levels.
To investigate the potential of N-acetylated amino acids in potentiating HDAC inhibitor efficacy for cancer therapeutics.

Main Methods:

More Related Videos

Author Spotlight: Epigenetic Modifications and Metabolic Rewiring as Targets for Cancer Therapy

Author Spotlight: Epigenetic Modifications and Metabolic Rewiring as Targets for Cancer Therapy

Published on: October 18, 2024

Automated Sample Preparation for the Multiplexed Analysis of Single-Cell Histone Post-Translational Modifications (sc-hPTM2)

Automated Sample Preparation for the Multiplexed Analysis of Single-Cell Histone Post-Translational Modifications (sc-hPTM2)

Published on: December 19, 2025

Related Experiment Videos

Last Updated: Mar 5, 2026

Extraction of Histones from Clinical Specimens for Epigenetic Profiling by Mass Spectrometry

Extraction of Histones from Clinical Specimens for Epigenetic Profiling by Mass Spectrometry

Published on: November 21, 2025

Author Spotlight: Epigenetic Modifications and Metabolic Rewiring as Targets for Cancer Therapy

Author Spotlight: Epigenetic Modifications and Metabolic Rewiring as Targets for Cancer Therapy

Published on: October 18, 2024

Automated Sample Preparation for the Multiplexed Analysis of Single-Cell Histone Post-Translational Modifications (sc-hPTM2)

Automated Sample Preparation for the Multiplexed Analysis of Single-Cell Histone Post-Translational Modifications (sc-hPTM2)

Published on: December 19, 2025

Utilized a panel of monoclonal antibodies and a novel technique, epigenetic reverse phase protein array (eRPPA).

Analyzed histone modifications in cancer cell lines treated with HDAC inhibitors.

Quantified changes in global histone acetylation abundance.

Main Results:

Observed a significant increase in histone acetylation levels within 2-24 hours after HDAC inhibition.
Demonstrated that N-acetylated amino acids can serve as acetyl donors, further enhancing histone acetylation.
Validated the eRPPA technique for fingerprinting global histone modification changes.

Conclusions:

The developed eRPPA assay provides a robust tool for drug screening and diagnostics in cancer research.
N-acetylated amino acids show potential as adjuncts to HDAC inhibitors, offering a novel therapeutic strategy.
Further research into these natural compounds is warranted for developing new, inexpensive cancer therapeutics.